Literature DB >> 29345967

Reclassifying Acute Respiratory Distress Syndrome.

Giorgia Maiolo1, Francesca Collino1, Francesco Vasques1, Francesca Rapetti1, Tommaso Tonetti1, Federica Romitti1, Massimo Cressoni2, Davide Chiumello2,3, Onnen Moerer1, Peter Herrmann1, Tim Friede4, Michael Quintel1, Luciano Gattinoni1.   

Abstract

RATIONALE: The ratio of PaO2 to FiO2 (P/F) defines acute respiratory distress syndrome (ARDS) severity and suggests appropriate therapies.
OBJECTIVES: We investigated 1) whether a 150-mm-Hg P/F threshold within the range of moderate ARDS (100-200 mm Hg) would define two subgroups that were more homogeneous; and 2) which criteria led the clinicians to apply extracorporeal membrane oxygenation (ECMO) in severe ARDS.
METHODS: At the 150-mm-Hg P/F threshold, moderate patients were split into mild-moderate (n = 50) and moderate-severe (n = 55) groups. Patients with severe ARDS (FiO2 not available in three patients) were split into higher (n = 63) and lower (n = 18) FiO2 groups at an 80% FiO2 threshold.
MEASUREMENTS AND MAIN RESULTS: Compared with mild-moderate ARDS, patients with moderate-severe ARDS had higher peak pressures, PaCO2, and pH. They also had heavier lungs, greater inhomogeneity, more noninflated tissue, and greater lung recruitability. Within 84 patients with severe ARDS (P/F < 100 mm Hg), 75% belonged to the higher FiO2 subgroup. They differed from the patients with severe ARDS with lower FiO2 only in PaCO2 and lung weight. Forty-one of 46 patients treated with ECMO belonged to the higher FiO2 group. Within this group, the patients receiving ECMO had higher PaCO2 than the 22 non-ECMO patients. The inhomogeneity ratio, total lung weight, and noninflated tissue were also significantly higher.
CONCLUSIONS: Using the 150-mm-Hg P/F threshold gave a more homogeneous distribution of patients with ARDS across the severity subgroups and identified two populations that differed in their anatomical and physiological characteristics. The patients treated with ECMO belonged to the severe ARDS group, and almost 90% of them belonged to the higher FiO2 subgroup.

Entities:  

Keywords:  acute respiratory distress syndrome; computed tomographic analysis; extracorporeal membrane oxygenation; lung inhomogeneity; mechanical ventilation

Mesh:

Year:  2018        PMID: 29345967     DOI: 10.1164/rccm.201709-1804OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

Review 1.  Phenotypes in acute respiratory distress syndrome: moving towards precision medicine.

Authors:  Pratik Sinha; Carolyn S Calfee
Journal:  Curr Opin Crit Care       Date:  2019-02       Impact factor: 3.687

2.  Is the mechanical power the final word on ventilator-induced lung injury?-we are not sure.

Authors:  Francesco Vasques; Eleonora Duscio; Iacopo Pasticci; Federica Romitti; Francesco Vassalli; Michael Quintel; Luciano Gattinoni
Journal:  Ann Transl Med       Date:  2018-10

3.  A personalized approach to the acute respiratory distress syndrome: recent advances and future challenges.

Authors:  Elena Spinelli; Domenico L Grieco; Tommaso Mauri
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Focus on ventilation and ARDS: recent insights.

Authors:  Audrey De Jong; Samir Jaber; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2019-10-16       Impact factor: 17.440

5.  Benefits and risks of the P/F approach.

Authors:  L Gattinoni; F Vassalli; F Romitti
Journal:  Intensive Care Med       Date:  2018-10-23       Impact factor: 17.440

6.  Fraction of Inspired Oxygen With Low-Flow Versus High-Flow Devices: A Simulation Study.

Authors:  Yuki Kojima; Ryozo Sendo; Naoko Okayama; Junichiro Hamasaki
Journal:  Cureus       Date:  2022-05-18

Review 7.  Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).

Authors:  İdil Çetin; Mehmet Topçul
Journal:  Biomed Rep       Date:  2020-10-16

8.  [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].

Authors:  M Pfeifer; S Ewig; T Voshaar; W Randerath; T Bauer; J Geiseler; D Dellweg; M Westhoff; W Windisch; B Schönhofer; S Kluge; P M Lepper
Journal:  Pneumologie       Date:  2020-04-22

9.  Integrating the evidence: confronting the COVID-19 elephant.

Authors:  John J Marini; R Phillip Dellinger; Daniel Brodie
Journal:  Intensive Care Med       Date:  2020-07-25       Impact factor: 17.440

10.  Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.

Authors:  Pratik Sinha; Kevin L Delucchi; B Taylor Thompson; Daniel F McAuley; Michael A Matthay; Carolyn S Calfee
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.